Related Experiment Video
Updated: Aug 8, 2026
Generation of Human CD40-activated B cells
Published on: October 17, 2009
Construction and expression of a soluble form of human CD30 ligand with functional activity
1Program in Molecular Biology, Loyola University School of Medicine, Maywood, Illinois 60153, USA.
Insights
Researchers developed a soluble CD30 Ligand (sCD30L/CD8alpha) to study CD30 signaling. This new tool confirms CD30L
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- CD30 engagement triggers diverse cellular responses including viability, proliferation, and NF-kappaB signaling.
- Previous methods using antibodies or transfected CD30 Ligand (CD30L) have limitations for studying CD30 function.
- Understanding CD30 signaling is crucial for its role in lymphoid cells.
Purpose of the Study:
- To develop a functional soluble human CD30 Ligand (sCD30L/CD8alpha) for studying CD30.
- To overcome limitations of existing methods for triggering CD30.
- To investigate the molecular basis of CD30 pleiotropism.
Main Methods:
- Generation and expression of a soluble CD30 Ligand fused to CD8alpha (sCD30L/CD8alpha).
- Immunoprecipitation and Western blot analysis to characterize sCD30L/CD8alpha forms.
- Binding assays using a soluble CD30 fusion protein (sCD30/gamma1).
- Functional assays assessing cell death and proliferation in CD30-expressing cell lines.
Main Results:
- sCD30L/CD8alpha exists in monomeric and trimeric forms.
- sCD30L/CD8alpha binds to CD30.
- Immobilized sCD30L/CD8alpha induces cell death and reduces proliferation in CD30-expressing cells.
- These effects are inhibitable by sCD30/gamma1.
Conclusions:
- sCD30L/CD8alpha is a useful tool for studying CD30 Ligand and CD30 function.
- Soluble CD30 Ligand molecules naturally trimerize.
- This study provides insights into the physiological mechanisms of CD30 signaling.
Abstract:
CD30 engagement in human lymphoid cells induces pleiotropic cellular responses that affect cellular viability and proliferation, cytokine production, and nuclear factor kappaB (NF-kappaB) nuclear translocation. Studies examining the molecular basis for this pleiotropism thus far have relied on the use of antibodies and cells transfected with CD30L to trigger CD30, two methods of receptor induction that present important limitations: antibodies are not physiological receptor-triggering molecules and CD30L transfectants induce high background intracellular signaling in the cells under study. We have generated and expressed a functional soluble human CD30L molecule (sCD30L/CD8alpha) comprised of the extracellular domain of human CD30L fused to the extracellular domain of the human CD8alpha chain. Immunoprecipitation and Western blot analysis of sCD30L/CD8alpha revealed the existence of at least two forms of sCD30L/CD8alpha, which exhibited molecular sizes consistent with the existence of monomeric and trimeric forms of the molecule. Binding analyses performed using a soluble CD30 fusion protein (sCD30/gamma1) confirmed the ability of sCD30L/CD8alpha to bind to CD30. Functionally, immobilized sCD30L/CD8alpha-induced cell death in the CD30-expressing lines Karpas-299 and HDLM-2 and reduced proliferative levels in Karpas-299; these effects were inhibitable by the addition of sCD30/gamma1. These studies demonstrate the utility of sCD30L/CD8alpha in characterizing the normal function of CD30L and CD30 and indicate the natural ability of soluble forms of CD30L to trimerize.
